Patents Assigned to Tecnogen S.p.A.
  • FGF2-binding peptides and uses thereof
    Patent number: 8076300
    Abstract: FGF2-binding peptides are here described, which have been designed starting from the N-terminal region of PTX3, in particular spanning the PTX3(82-11O) region. Synthetic peptides related to this sequence are able to bind FGF2 and to inhibit its pro-angiogenic activity in vitro and in vivo with no anticipated impact on innate immunity.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: December 13, 2011
    Assignee: Tecnogen S.p.A.
    Inventors: Marco Presta, Maura Camozzi, Marco Rusnati, Maurizio Colombo, Domenico Mastroianni
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20110224132
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 15, 2011
    Publication date: September 15, 2011
    Applicant: TECNOGEN S.P.A
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • Vector for efficient selection and/or maturation of an antibody and uses thereof
    Patent number: 8003383
    Abstract: It is described a vector suitable for efficient selection and/or maturation of a recombinant antibody characterized in that it contains at least one element able to reduce the expression level and/or has an improved efficiency of display of said recombinant antibody.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: August 23, 2011
    Assignees: Sigma Tau Industrie Farmaceutiche Riunite S.pA., Tecnogen S.p.A.
    Inventors: Olga Minenkova, Emiliano Pavoni
  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 7910092
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: March 22, 2011
    Assignee: Tecnogen S.p.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20090286726
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 28, 2007
    Publication date: November 19, 2009
    Applicant: TECNOGEN S.P.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza